Citadel Advisors’s Ping An Biomedical PASW Stock Holding History

Citadel Advisors’s Portfolio PASW Stock Details PASW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-22,886	Closed	-$11.5K	–	14762
2025 Q4	$11.5K	Buy	22,886 +593	+3%	+$396	﹤0.01%	12424
2025 Q3	$27.6K	Buy	+22,293	New	+$32.9K	﹤0.01%	12421

Other funds holding PASW

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Citadel Advisors's PASW Position: Q1 2026 in Review

Citadel Advisors sold out of Ping An Biomedical (PASW) in Q1 2026, closing a stake of 22,886 shares — an estimated $11.5K sold.

Citadel Advisors first reported a position in PASW in Q3 2025 and held it in 2 quarters. The position peaked at $27.6K in Q3 2025. 4 funds tracked by Wall St. Rank hold PASW as of Q1 2026.

Citadel Advisors reported no remaining Ping An Biomedical position as of Q1 2026 after selling out during the quarter.
Citadel Advisors sold 22,886 Ping An Biomedical shares in Q1 2026, an estimated $11.5K.
Citadel Advisors first reported a position in Ping An Biomedical in Q3 2025 and held it in 2 quarters.
Citadel Advisors's Ping An Biomedical position peaked at $27.6K in Q3 2025.
4 funds tracked by Wall St. Rank held Ping An Biomedical as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.